Original article
Pediatric cardiac
Wang-Zwische Double-Lumen Cannula Leads to Total Cavopulmonary Support in a Failing Fontan Sheep Model

Presented at the Basic Science Forum of the Fifty-seventh Annual Meeting of the Southern Thoracic Surgical Association, Orlando, FL, Nov 3–6, 2010.
https://doi.org/10.1016/j.athoracsur.2011.02.031Get rights and content

Background

We are developing a total cavopulmonary support system for failing Fontan physiology using the percutaneous Wang-Zwische double-lumen cannula (DLC).

Methods

We developed a sheep model of failing Fontan physiology through a right thoracotomy in 5 sheep. An extracardiac conduit was anastomosed to the inferior vena cava and superior vena cava, and a graft was applied to connect the conduit and the right pulmonary artery (PA) to create total vena cava-to-PA diversion, excluding the right heart. The DLC (commercialized as AvalonElite, Avalon Laboratories LLC, Rancho Dominguez, CA) was coupled with a CentriMag pump (Levitronix Waltham, MA) to form a cavopulmonary support system. The DLC was inserted through the right jugular vein and the superior vena cava into the extracardiac conduit with the infusion lumen opening aligned with the right PA bridge. Blood was withdrawn from the superior vena cava and the inferior vena cava through the drainage lumen and pumped into the right PA through the infusion lumen, with flow adjusted to 4.0 ± 0.5 L/min.

Results

A successful Fontan model was created without cardiopulmonary bypass. After total venous blood diversion from the vena cava to the right PA artery, failing Fontan physiology developed, evidenced by elevated central venous pressure and dropping mean PA pressure and systolic arterial pressure. The DLC was successfully inserted, and hemodynamics were normalized in all 5 sheep for the duration of the 2-hour study.

Conclusions

We created a model of failing Fontan circulation in sheep without cardiopulmonary bypass. The DLC system achieved total cavopulmonary support for 2 hours in our failing Fontan sheep model.

Section snippets

The DLC-Based CPAD

Our percutaneous CPAD consists of our patented DLC (AvalonElite, Avalon Laboratories LLC, Rancho Dominguez, CA) and a compact CentriMag pump (Levitronix Waltham, MA). The DLC is the critical component and is inserted from the jugular vein into the SVC and extracardiac conduit. The infusion opening is aligned with the right PA (RPA), the proximal drainage openings are positioned in SVC above the Fontan anastomosis for upper body venous drainage, and the distal end drainage openings are

Results

A successful failing Fontan model was created in the 5 sheep without cardiopulmonary bypass support (Fig 1B). After clamps were placed on the SVC and IVC between the right atrium and anastomosis, total venous blood was diverted from the SVC/IVC to the RPA through the extracardiac conduit into the pulmonary system, bypassing the right atrium and RV. Because there is no RV in the pulmonary circulation, an elevated CVP cannot overcome the high resistance from the long conduit and the limited size

Comment

The Fontan procedure is lifesaving for many patients but confers high morbidity and mortality both short-term and long-term because of failing Fontan circulation. Venoarterial ECMO is currently the best option to assist the patient with failing Fontan circulation [6, 7, 8]. However, ECMO has a time limit, is labor intensive, expensive, and traumatic to the blood. The bulky ECMO system includes an oxygenator, complex circuit, and full anticoagulation. ECMO is also nonambulatory and is associated

Cited by (22)

  • Current Understanding and Future Directions of Transcatheter Devices to Assist Failing Fontan

    2024, Journal of the Society for Cardiovascular Angiography and Interventions
  • Large Animal Models of Heart Failure: A Translational Bridge to Clinical Success

    2020, JACC: Basic to Translational Science
    Citation Excerpt :

    One example is the CentriMag Circulatory ventricular assist device (Abbott Laboratories, Abbott Park, Illinois), which was recalled due to a calibrating system error linked to electromagnetic interference, which caused the device to stop (https://www.fda.gov/medical-devices/medical-device-recalls/abbott-recalls-centrimag-circulatory-support-system-motor-due-pump-and-motor-issues). Difficulties with the device occurred after FDA approval, despite several preclinical studies in both sheep (164−166) and pigs (167), 3 registered clinical trials (Table 2) (CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass; NCT00819793 [completed]; CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients; NCT01171950 [withdrawn]; and CentriMag RVAS U.S. Post-approval Study Protocol [CMagRVAS]; NCT01568424 [completed]), and a multicenter study that showed short-term support with low incidence of device-related complications and no device failure in cardiogenic shock patients 30 days after CentriMag implantation (168). These findings are not meant to undermine the importance of integrating preclinical and clinical studies for assessing safety and feasibility during development, but rather to highlight that work still remains regarding optimization of current systems that facilitate testing and/or approval of new therapies and devices.

  • Heart transplantation in adults for Fontan failure

    2016, Progress in Pediatric Cardiology
    Citation Excerpt :

    Case reports in the literature describe off-label use of ventricular assist devices in univentricular patients [23], with a higher complication rate than two ventricular patients [24–26]. Wang et al. developed a failing Fontan sheep model to test cavopulmonary assist devices [27]. Impella-like devices specifically designed for Fontan circulation show the most promise [28,29].

  • Physics-driven impeller designs for a novel intravascular blood pump for patients with congenital heart disease

    2016, Medical Engineering and Physics
    Citation Excerpt :

    Flow is provided by an external CentriMag pump and the umbrellas are collapsible in the event of pump failure [27]. The device has been tested in sheep models [27-29]. Recirculation regions exist around the inlets to the cannula as well as stagnation regions on both sides of the umbrellas that may lead to thrombus formation.

  • Effect of mechanical assistance of the systemic ventricle in single ventricle circulation with cavopulmonary connection

    2014, Journal of Thoracic and Cardiovascular Surgery
    Citation Excerpt :

    The inherent inefficiencies of the Fontan circulation, however, have led to delayed Fontan failure in some patients and can lead to late mortality and morbidity.6-9 Previous reports have focused on mechanical assistance for this failing circulation using subpulmonary blood pumps to drive the blood forward through the pulmonary circuit4,5,10-14 or a viscous impeller pump, based on the Von Karman principle.3,15 Although clinical success10 has been seen with this approach of pushing blood through the pulmonary circuit, significant surgical modifications to the existing cavopulmonary circuit, or custom-made pumps are required to implement this strategy.

View all citing articles on Scopus
View full text